We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Dermatology

Journal Scan / Research · March 09, 2021

Corticosteroid vs Vincristine for Kaposiform Hemangioendothelioma and Tufted Angioma

The Journal of Dermatology

 

Additional Info

The Journal of Dermatology
Comparison of Efficacy and Safety of Corticosteroid and Vincristine in Treating Kaposiform Hemangioendothelioma and Tufted Angioma: A Multicenter Prospective Randomized Controlled Clinical Trial
J Dermatol 2021 Feb 19;[EPub Ahead of Print], W Yao, K Li, Z Wang, J Wang, Y Ji, L Zhou, H Huang, X Gao, Z Huang, S Gu, H Yang, S Zheng

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading